Cargando…

Inactivation of airborne SARS-Co-V2 using NTP-UVGI hybrid process

Indoor environments such as healthcare centers are known as one of the key centers in the outbreak of viral infectious diseases. In the present study, the pathogenic agents' treatment system (PATS) was designed by the combination of non-thermal plasma (NTP) with the ultraviolet germicidal irrad...

Descripción completa

Detalles Bibliográficos
Autores principales: Yarahmadi, R., Soleimani-Alyar, S., Darvishi, M.-M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593994/
https://www.ncbi.nlm.nih.gov/pubmed/36313941
http://dx.doi.org/10.1007/s13762-022-04399-y
_version_ 1784815301841387520
author Yarahmadi, R.
Soleimani-Alyar, S.
Darvishi, M.-M.
author_facet Yarahmadi, R.
Soleimani-Alyar, S.
Darvishi, M.-M.
author_sort Yarahmadi, R.
collection PubMed
description Indoor environments such as healthcare centers are known as one of the key centers in the outbreak of viral infectious diseases. In the present study, the pathogenic agents' treatment system (PATS) was designed by the combination of non-thermal plasma (NTP) with the ultraviolet germicidal irradiation (UVGI) processes. Then, the treatment efficiency of PATS was measured for the "SARS-Co-V2." The exhaled air of the confirmed case of "COVID-19" was considered as the viral source of "SARS-Co-V2" and directed to the upstream of PATS. The treatment process was done by passing directed air through two steps of treatment (NTP and UVGI). The treatment efficiency of PATS was measured by sampling at the sampling points (before and after the treatment process). According to the energy emission pattern (corona discharge, UV rays) in the designed system, during two steps, the high efficiency of treatment for the collected pathogens was achieved. Based on the real-time polymerase chain reaction (RT-PCR) results, the CT value was lower than 29 (CTs < 29), and after the treatment using PATS was upper than 40 (CTs > 40) confirming the highest removal efficiency of "SARS-Co-V2." Also, the treatment efficiency of each reactor in individual operation was at the optimum level. The findings suggested, the present PATS may eliminate the viral pathogens with hospital sources and also, be applicable in the other intensive care unit (ICU) wards with the same risk thus, significantly reducing the possible exposure risk of healthcare and sick companions, and preventing the outbreak of infectious diseases.
format Online
Article
Text
id pubmed-9593994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95939942022-10-25 Inactivation of airborne SARS-Co-V2 using NTP-UVGI hybrid process Yarahmadi, R. Soleimani-Alyar, S. Darvishi, M.-M. Int J Environ Sci Technol (Tehran) Original Paper Indoor environments such as healthcare centers are known as one of the key centers in the outbreak of viral infectious diseases. In the present study, the pathogenic agents' treatment system (PATS) was designed by the combination of non-thermal plasma (NTP) with the ultraviolet germicidal irradiation (UVGI) processes. Then, the treatment efficiency of PATS was measured for the "SARS-Co-V2." The exhaled air of the confirmed case of "COVID-19" was considered as the viral source of "SARS-Co-V2" and directed to the upstream of PATS. The treatment process was done by passing directed air through two steps of treatment (NTP and UVGI). The treatment efficiency of PATS was measured by sampling at the sampling points (before and after the treatment process). According to the energy emission pattern (corona discharge, UV rays) in the designed system, during two steps, the high efficiency of treatment for the collected pathogens was achieved. Based on the real-time polymerase chain reaction (RT-PCR) results, the CT value was lower than 29 (CTs < 29), and after the treatment using PATS was upper than 40 (CTs > 40) confirming the highest removal efficiency of "SARS-Co-V2." Also, the treatment efficiency of each reactor in individual operation was at the optimum level. The findings suggested, the present PATS may eliminate the viral pathogens with hospital sources and also, be applicable in the other intensive care unit (ICU) wards with the same risk thus, significantly reducing the possible exposure risk of healthcare and sick companions, and preventing the outbreak of infectious diseases. Springer Berlin Heidelberg 2022-10-25 2023 /pmc/articles/PMC9593994/ /pubmed/36313941 http://dx.doi.org/10.1007/s13762-022-04399-y Text en © The Author(s) under exclusive licence to Iranian Society of Environmentalists (IRSEN) and Science and Research Branch, Islamic Azad University 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Paper
Yarahmadi, R.
Soleimani-Alyar, S.
Darvishi, M.-M.
Inactivation of airborne SARS-Co-V2 using NTP-UVGI hybrid process
title Inactivation of airborne SARS-Co-V2 using NTP-UVGI hybrid process
title_full Inactivation of airborne SARS-Co-V2 using NTP-UVGI hybrid process
title_fullStr Inactivation of airborne SARS-Co-V2 using NTP-UVGI hybrid process
title_full_unstemmed Inactivation of airborne SARS-Co-V2 using NTP-UVGI hybrid process
title_short Inactivation of airborne SARS-Co-V2 using NTP-UVGI hybrid process
title_sort inactivation of airborne sars-co-v2 using ntp-uvgi hybrid process
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593994/
https://www.ncbi.nlm.nih.gov/pubmed/36313941
http://dx.doi.org/10.1007/s13762-022-04399-y
work_keys_str_mv AT yarahmadir inactivationofairbornesarscov2usingntpuvgihybridprocess
AT soleimanialyars inactivationofairbornesarscov2usingntpuvgihybridprocess
AT darvishimm inactivationofairbornesarscov2usingntpuvgihybridprocess